US Oncology Research Investigational Products Center /ID# 278746 — Irving, Texas

US Oncology Research Investigational Products Center /ID# 278746 is a clinical research site located in Irving, Texas, United States 75063.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

US Oncology Research Investigational Products Center /ID# 278746 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Sponsors: AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Irving

Browse all research sites in Texas · View every site in Irving

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for US Oncology Research Investigational Products Center /ID# 278746?

US Oncology Research Investigational Products Center /ID# 278746 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has US Oncology Research Investigational Products Center /ID# 278746 conducted?

US Oncology Research Investigational Products Center /ID# 278746 has 1 clinical trials on record, with 1 currently active. Their work covers Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer.

Is US Oncology Research Investigational Products Center /ID# 278746 accredited by Crixeo Clinical Trials?

US Oncology Research Investigational Products Center /ID# 278746 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about US Oncology Research Investigational Products Center /ID# 278746?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.